Key result
Hyperlipidemia impairs nitric oxide and promotes vasoconstriction and thrombosis to drive atherosclerosis.
Why the study?
Hyperlipidemia may compromise endothelial nitric oxide release or action and induce production of vasoconstrictor, mitogenic, and prothrombotic factors, contributing to atherosclerotic vascular disease.
Supports lipid-lowering to preserve endothelial function; extends mechanistic insights into atherosclerosis but remains hypothesis-generating.
The normal endothelium exerts an important protective influence on the vessel wall by producing the potent vasodilator factor, nitric oxide, which also inhibits platelet deposition and smooth muscle cell proliferation. Evidence indicating that hyperlipidemia can compromize the release or action of endothelium-derived nitric oxide is reviewed. Also, lipid disorders may induce the production by endothelium of vasoconstrictor and mitogenic factors, including endothelin-1, and the prothrombotic factor, plasminogen activator inhibitor-1. Together, these abnormalities in endothelial cell synthetic function caused by hyperlipidemias may contribute to the development and clinical manifestations of atherosclerotic vascular disease.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (1993) conducted a review in Hyperlipidemia. Hyperlipidemia was evaluated. Hyperlipidemia compromises endothelium-derived nitric oxide and induces vasoconstrictor and prothrombotic factors, contributing to the development of atherosclerotic vascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: